Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -35,653 | -24,336 | -29,485 |
| Depreciation Amortization | 900 | 596 | 1,037 |
| Accounts payable and accrued liabilities | -1,190 | -319 | N/A |
| Other Working Capital | 3,735 | 1,599 | 1,895 |
| Other Operating Activity | -531 | -821 | -3,913 |
| Operating Cash Flow | $-32,739 | $-23,281 | $-30,466 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -242 | -182 | -1,773 |
| Investing Cash Flow | $-242 | $-182 | $-1,773 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -220 | -155 | N/A |
| Common Stock Issued | 435 | 2 | N/A |
| Other Financing Activity | 0 | 0 | 62,190 |
| Financing Cash Flow | $215 | $-153 | $62,190 |
| Beginning Cash Position | 66,090 | 66,090 | 36,139 |
| End Cash Position | 33,324 | 42,474 | 66,090 |
| Net Cash Flow | $-32,766 | $-23,616 | $29,951 |
| Free Cash Flow | |||
| Operating Cash Flow | -32,739 | -23,281 | -30,466 |
| Capital Expenditure | -242 | -182 | N/A |
| Free Cash Flow | -32,981 | -23,463 | -30,466 |